Work

Figure S2 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors

Year: 2026

Type: other

Abstract: Supplementary Figure 2. Validation of CD91 deletion in cDC1.

DOI: 10.1158/2326-6066.32697991

Authors: Devanshi A. Nayak, Abigail L. Sedlacek, Anthony R. Cillo, Simon C. Watkins, Robert J. Binder

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165034227

Cites:

Cited by:

Related to: 10